[Washington, D.C., 20 June 2025] – The U.S. clinical nutrition market is projected to grow from USD 20.3 billion in 2024 to USD 32.1 billion by 2031, according to Clearview Market Insights (CVMI). With the expansion of post-acute care models and the increasing prevalence of chronic diseases, the demand for personalized, reimbursable nutrition solutions is rising.
"Nutrition therapy is rapidly moving from hospital beds to home kitchens, powered by digital platforms and AI-guided plans," said Dr. Rachel Simmons, CVMI’s Director of U.S. Healthcare Services.
Key Highlights:
- Hospitals advancing EMR-linked nutritional assessments across inpatient care
- Smart pumps and digital diet coaching adopted in outpatient cancer nutrition
- Abbott and Nestlé lead innovation in tailored ONS and GI disease nutrition
Segment Expansion and Consumer Demand:
There is a rising demand from patients for customized nutrition programs targeting specific conditions such as cancer cachexia, post-surgical healing, and diabetic recovery. Oral nutritional supplements (ONS) are increasingly prescribed in outpatient and transitional care, with improved integration into discharge planning workflows. Consequently, retailers and pharmacies are working together with clinical providers to co-manage compliance.
Home Nutrition and Technology Adoption:
Home-based enteral and parenteral nutrition therapy is gaining traction due to enhanced patient outcomes and cost savings. Smart enteral feeding pumps, cloud-connected PN kits, and remote dietitian consultations are now reimbursed by major insurers. This trend is particularly noticeable among oncology, neurology, and pediatric patient populations.
Policy Trends and Reimbursement Clarity:
New CMS guidelines on malnutrition coding have enhanced documentation and reimbursement, leading to improved integration of nutrition in care planning. Medicare Advantage and Medicaid waiver programs in several states now provide coverage for nutrition therapy in chronic and post-acute care management.
Innovation in Product Development:
Abbott's SmartMeal AI platform and Nestlé's Boost GI line are transforming personalized meal prescriptions, while Danone is testing plant-based medical nutrition for metabolic syndromes. Fresenius Kabi is facilitating compounding customization for high-risk PN patients through Epic-integrated modules.
Future Outlook:
By 2031, clinical nutrition will become a core pillar of personalized medicine in U.S. hospitals. AI-assisted nutrition therapy planning, predictive risk assessment, and reimbursement-linked outcome tracking will lead the next wave of growth.
For more insights, visit https://clearviewmarketinsights.com/report-store
About Clearview Market Insights
Clearview Market Insights is a global research and consulting firm that delivers forward-looking intelligence across more than 100 healthcare, biotechnology, and pharmaceutical markets. Our analysts synthesize real-time data, executive insights, and strategic models to support decision-making at the highest levels.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
Top of Form
Bottom of Form
